The short version of incretin fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2026-03-20. Anything still debated is marked as such rather than presented as settled.
Verification of research-grade material involves checking purity, sequence and counter-ion content against a certificate of analysis. Reported purity figures usually reflect chromatographic area percentage and do not by themselves establish biological activity. Independent laboratories may repeat mass confirmation and peptide mapping to detect substitutions or truncations. Open questions concern how residual solvents, trace metals and subtle conformational variants affect measured behavior, and how consistently different suppliers define their specifications. Documentation of analytical methods matters as much as the headline purity number when results are compared across studies.
Routine characterization relies on reversed-phase high-performance liquid chromatography, often coupled to mass spectrometry, to confirm identity and estimate purity. Peptide mapping after enzymatic digestion verifies the amino acid sequence and locates appended groups such as the fatty acid chain. Size-exclusion chromatography detects aggregates and fragments, while ion-exchange chromatography resolves charge variants. Circular dichroism and nuclear magnetic resonance supply secondary and higher-order structural information in research settings. No single technique covers every attribute, so laboratories combine orthogonal methods and compare outcomes against a reference standard where one exists.
Both receptors are class B G protein-coupled receptors that signal largely through Gs-mediated cyclic AMP production. Activation within pancreatic islets increases glucose-dependent insulin secretion and suppresses glucagon release when glucose is elevated. Outside the pancreas, signaling in the central nervous system and gut appears to influence appetite and gastric emptying. The relative contribution of each receptor to observed clinical effects remains under investigation, and the two pathways are not simply additive in practice.
Reported outcomes in large trials include dose-dependent weight reduction and improvements in glycemic markers over periods ranging from several months to more than a year. Whether the compound alters long-term cardiovascular or renal outcomes is being examined in dedicated outcome studies, so those questions remain open. Labeling describes gastrointestinal effects such as nausea and diarrhea, which tend to appear during dose escalation. Discontinuation rates and the durability of effects after treatment stops vary across study populations and are still debated.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white lyophilized powder | Visual inspection serves only as a preliminary check |
| Solubility | Freely soluble in water and aqueous buffers | Gentle mixing may be needed to reach full dissolution |
| Typical storage | Minus 20 degrees Celsius or colder, desiccated, protected from light | Avoid repeated freeze-thaw cycles |
| Primary analytical method | Reversed-phase HPLC with mass detection | Purity reported as chromatographic area percent |
| Common synonyms | GIP/GLP-1 dual agonist; LY3298176 | Development codes are distinct from approved product names |
Clinical development proceeded through large phase 3 programmes in type 2 diabetes and in obesity or overweight with at least one weight-related comorbidity. Regulatory approvals followed in several jurisdictions for both indications. Weekly subcutaneous dosing reflects an elimination half-life of roughly five days. Open questions include the durability of metabolic effects after treatment stops, long-term cardiovascular and hepatic outcomes beyond completed trials, and whether the dual mechanism confers benefits independent of total receptor occupancy. Published literature continues to expand on these points. Substantial uncertainty remains about interindividual variability in response.
Tirzepatide is a synthetic linear peptide of 39 amino acids that acts as a dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Its sequence derives from native GIP but incorporates non-natural residues and a C20 fatty diacid moiety linked to a lysine side chain. The lipophilic chain promotes albumin binding, which slows renal clearance and extends circulation time. The unmodified peptide has a molecular formula of C225H348N48O68 and a molecular mass near 4,813 daltons.
Pharmacologically, tirzepatide activates two distinct G protein-coupled receptors: the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor. Binding at each target triggers cyclic AMP accumulation and downstream signaling in pancreatic beta cells, adipose tissue and the central nervous system. Because the two pathways overlap only partially, the combined effect on insulin secretion, glucagon suppression and appetite signaling differs from that of selective single-receptor compounds. Affinity is not equal across the two targets, and the clinical meaning of that imbalance remains an area of active study.
Clinical research programs have evaluated tirzepatide in adults with type 2 diabetes and in adults with obesity or excess weight. Trials generally reported reductions in glycated hemoglobin and body weight across treatment periods of several months. Since these studies enrolled defined populations under controlled conditions, the findings describe group averages rather than individual outcomes. Open questions include the durability of effects after treatment stops, variation among subgroups, and the long-term consequences of sustained dual receptor stimulation. Published trial summaries should be consulted for exact measurements rather than secondary accounts.
Research-grade material circulates through suppliers that differ widely in documentation and testing practice, so a certificate of analysis is a starting point rather than proof of quality. Independent verification typically repeats chromatographic purity and mass confirmation on the received lot, and compares results against a retained reference standard. Regulatory status varies by jurisdiction, and a substance cleared as a medicine is not interchangeable with a research chemical of the same name. Open questions include how closely non-pharmaceutical lots match approved material in impurity profile and in aggregate content.
Solid tirzepatide is handled as a lyophilised, hygroscopic peptide powder that should be kept desiccated, protected from light, and stored frozen, typically at or below minus twenty degrees Celsius for long-term retention. Material left at ambient temperature for extended periods can take up moisture, which promotes aggregation and deamidation. Commercial liquid presentations are kept refrigerated between two and eight degrees Celsius and are not frozen. Reconstituted laboratory solutions are generally held cold and used within a short window because hydrolysis and oxidation continue slowly in solution.
Long-term storage of the solid generally relies on temperatures at or below minus twenty degrees Celsius, while short-term working stocks may be held refrigerated. Light exposure is limited because photodegradation can alter side chains over extended periods. Solutions prepared for analysis are less stable than the dry powder and are typically used within the same working day. Buffer choice matters, since some aqueous conditions favor deamidation or oxidation at specific residues. Stability data are usually generated under defined accelerated conditions and then extrapolated with stated assumptions.
Identity and purity are established with reversed-phase high-performance liquid chromatography, often paired with mass spectrometry for confirmation of the expected mass. Peptide mapping after enzymatic digestion verifies the primary sequence and detects substitutions. Size-exclusion chromatography quantifies aggregates and fragments, which are the impurities most often tracked for peptides of this size. Residual solvents, counterions, and water content fall under separate tests described in pharmacopeial chapters. Circular dichroism or nuclear magnetic resonance may be used in research settings to probe secondary structure, though such methods are less common in routine release testing.
reverse genetics An experimental approach in molecular genetics in which a researcher starts with a known gene and attempts to determine its function or its effect on phenotype by any of a variety of laboratory techniques, commonly by deliberately mutating the gene's DNA sequence or by repressing or silencing its expression and then screening the mutant organisms for changes in phenotype. When the gene of interest is the only one in the genome whose expression has been manipulated, any observed phenotypic changes are assumed to be influenced by it. This is the opposite of forward genetics, in which a known phenotype is linked to one or more unknown genes.
=== Space physics === The study of space plasmas near Earth and throughout the Solar System is known as space physics. Researched areas within space physics encompass a wide range of topics, including the ionosphere,auroras, Earth's magnetosphere, the solar wind, and coronal mass ejections. MHD provides a framework for understanding how plasma populations interact within the local geospace environment. Researchers have developed global models using MHD to simulate phenomena within Earth's magnetosphere, such as the location of Earth's magnetopause (the boundary between Earth's magnetic field and the solar wind), the formation of the ring current, auroral electrojets, and geomagnetically induced currents. One prominent use of global MHD models is space weather forecasting. Intense solar storms have the potential to cause extensive damage to satellites and infrastructure; thus, it is crucial that such events be detected early. The Space Weather Prediction Center (SWPC) uses MHD models to predict the arrival and impacts of space weather events at Earth.
The reaction catalysed by an enzyme uses exactly the same reactants and produces exactly the same products as the uncatalysed reaction. Like other catalysts, enzymes do not alter the position of equilibrium between substrates and products. However, unlike uncatalysed chemical reactions, enzyme-catalysed reactions display saturation kinetics. For a given enzyme concentration and for relatively low substrate concentrations, the reaction rate increases linearly with substrate concentration; the enzyme molecules are largely free to catalyse the reaction, and increasing substrate concentration means an increasing rate at which the enzyme and substrate molecules encounter one another. However, at relatively high substrate concentrations, the reaction rate asymptotically approaches the theoretical maximum; the enzyme active sites are almost all occupied by substrates resulting in saturation, and the reaction rate is determined by the intrinsic turnover rate of the enzyme. The substrate concentration midway between these two limiting cases is denoted by KM. Thus, KM is the substrate concentration at which the reaction velocity is half of the maximum velocity. The two important properties of enzyme kinetics are how easily the enzyme can be saturated with a substrate, and the maximum rate it can achieve. Knowing these properties suggests what an enzyme might do in the cell and can show how the enzyme will respond to changes in these conditions.
The dividing line between metals and nonmetals is roughly diagonal from top left to bottom right, with the transition series appearing to the left of this diagonal (as they have many available orbitals for overlap). This is expected, as metallicity tends to be correlated with electropositivity and the willingness to lose electrons, which increases right to left and up to down. Thus the metals greatly outnumber the nonmetals. Elements near the borderline are difficult to classify: they tend to have properties that are intermediate between those of metals and nonmetals, and may have some properties characteristic of both. They are often termed semimetals or metalloids. The term "semimetal" used in this sense should not be confused with its strict physical sense having to do with band structure: bismuth is physically a semimetal, but is generally considered a metal by chemists. The following table considers the most stable allotropes at standard conditions. The elements coloured yellow form simple substances that are well-characterised by metallic bonding. Elements coloured light blue form giant network covalent structures, whereas those coloured dark blue form small covalently bonded molecules that are held together by weaker van der Waals forces. The noble gases are coloured in violet: their molecules are single atoms and no covalent bonding occurs. Greyed-out cells are for elements which have not been prepared in sufficient quantities for their most stable allotropes to have been characterized in this way.
Sources: en.wikipedia.org
Alan Dershowitz, Claus's attorney, wrote a book about the case, Reversal of Fortune: Inside the von Bülow Case (New York, Random House 1986 and London, Penguin Books 1991). The 1990 film Reversal of Fortune was based on Dershowitz's books about the case, with Glenn Close playing Sunny and Jeremy Irons playing Claus von Bülow, a performance for which he was awarded an Academy Award for Best Actor. Bill Kurtis narrated an episode of the series American Justice titled "Von Bulow: A Wealth of Evidence". The American television series Biography produced and aired a documentary episode titled "Claus von Bülow: A Reasonable Doubt", with interviews of Claus Von Bülow and Alan Dershowitz. The case is referenced in the Seinfeld episode "The Suicide". Jerry Seinfeld is in a hospital room watching over a comatose neighbor. To the neighbor's ex-girlfriend he remarked, "It's not like a Sunny Von Bülow coma. Doctor said he should snap out of it anytime." Sunny is referenced in the American television show Will & Grace, in which socialite Karen Walker asks more than once about Sunny being “out of bed.”
== Importance in medicine == Fehling's solution was used for many years as a diagnostic test for diabetes, a disease in which blood glucose levels are dangerously elevated by a failure to produce enough insulin (type 1 diabetes) or by an inability to respond to insulin (type 2 diabetes). Measuring the amount of oxidizing agent (in this case, Fehling's solution) reduced by glucose makes it possible to determine the concentration of glucose in the blood or urine. This then enables the right amount of insulin to be injected to bring blood glucose levels back into the normal range.
As he neared death after suffering strokes, Lenin's Testament of December 1922 named Trotsky and Stalin as the most able men in the Central Committee, but he harshly criticised them. Lenin said that Stalin should be removed from being the General Secretary of the party and that he be replaced with "some other person who is superior to Stalin only in one respect, namely, in being more tolerant, more loyal, more polite, and more attentive to comrades." Upon his death on 21 January 1924, Lenin's political testament was read aloud to the Central Committee, who chose to ignore Lenin's ordered removal of Stalin as General Secretary because enough members believed Stalin had been politically rehabilitated in 1923. Consequent to personally spiteful disputes about the praxis of Leninism, the October Revolution veterans Lev Kamenev and Grigory Zinoviev said that the true threat to the ideological integrity of the party was Trotsky, who was a personally charismatic political leader as well as the commanding officer of the Red Army in the Russian Civil War and revolutionary partner of Lenin. To thwart Trotsky's likely election to head the party, Stalin, Kamenev and Zinoviev formed a troika that featured Stalin as General Secretary, the de facto centre of power in the party and the country. The direction of the party was decided in confrontations of politics and personality between Stalin's troika and Trotsky over which Marxist policy to pursue, either Trotsky's policy of permanent revolution or Stalin's policy of socialism in one country.
Piggott; Fermented Beverage Production, Kluwer Academic/Plenum Publishers, 2003, ISBN 0-306-47706-8 McFarland, Ben; World's Best Beers, Sterling Publishing, 2009, ISBN 978-1-4027-6694-7 Oliver, Garrett (ed); The Oxford Companion to Beer, Oxford University Press, 2011 Priest, Fergus G.; Handbook of Brewing, CRC Press, 2006, ISBN 0-8247-2657-X Rabin, Dan and Forget, Carl; The Dictionary of Beer and Brewing, Fitzroy Dearborn/Taylor & Francis, 1998 ISBN 978-1-57958-078-0 Stevens, Roger, et al.; Brewing: Science and Practice, Woodhead Publishing, 2004, ISBN 0-8493-2547-1 Unger, Richard W.; Beer in the Middle Ages and the Renaissance, University of Pennsylvania Press, 2004, ISBN 0-8122-3795-1
=== Critical reviews === "You Hurled Me Into the Depths, Into the Very Heart of the Seas" received mostly positive reviews from critics. Matt Schimkowitz of The A.V. Club gave the episode an "A–" grade and wrote, "Not to be hyperbolic, but tonight's Righteous Gemstones was the funniest 36 minutes in television history. Okay, I won't go that far, but it was a series high. There wasn't a single punchline that didn't hit, a costume choice (or lack thereof) that wasn't a godsend, or a needle drop that was out of place. “You Hurled Me Into the Depths, Into the Very Heart Of The Seas” launches the final season's story out of the deep and finds the production confidently and hilariously ascending toward that big disco ball in the sky." Scott Tobias of Vulture gave the episode a 4 star rating out of 5 and wrote, "As lowbrow laughs go, there's nothing funnier than full-frontal male nudity, and there's certainly no funnier moment than Baby Billy dropping his drawers in front of the Gemstones in the dressing room after their rehearsal goes awry. “Behold, look at this.
Sources: en.wikipedia.org
Liquid chromatography combined with mass spectrometry is the most common approach. Digestion followed by peptide mapping verifies the sequence and modification sites. Results are judged against a reference standard or a theoretically calculated mass.
Lower temperatures slow most degradation routes, and storage at minus twenty degrees Celsius or below is standard for lyophilized material. Repeated warming and cooling imposes stress on the molecule. Dissolved samples deteriorate faster and are usually handled over shorter periods.
It normally reflects the relative chromatographic area of the principal peak. It does not capture every possible impurity or demonstrate biological function. Additional methods are required to describe a sample completely.
It acts as an agonist at both the GIP and GLP-1 receptors, two related class B G protein-coupled receptors. This dual activity distinguishes it from single-receptor GLP-1 agonists. The clinical consequences of engaging both receptors are still being characterized.